Published in Biochem J on November 15, 1981
Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med (1989) 1.27
Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients (2012) 1.21
Complement-mediated killing of microtumors in vitro. Am J Pathol (1998) 0.93
The role of vitamin D in pregnancy and lactation: emerging concepts. Womens Health (Lond Engl) (2012) 0.84
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors. Invest New Drugs (2010) 0.81
Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science (1979) 2.57
Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). N Engl J Med (1977) 2.39
Oestrogen-responsive human breast cancer in long term tissue culture. Nature (1975) 1.56
A modified fluorometric method for the determination of microgram quantities of DNA from cell or tissue cultures. Anal Biochem (1976) 1.56
A specific high-affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone. Science (1977) 1.38
1,25-dihydroxyvitamin-D-receptor in breast cancer cells. Lancet (1980) 1.22
Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands. Proc Natl Acad Sci U S A (1975) 1.16
A receptor-like binding macromolecule for 1 alpha, 25-dihydroxycholecalciferol in cultured mouse bone cells. J Biol Chem (1979) 1.12
Receptors for 1,25(OH)2-vitamin D3 enriched in cloned osteoblast-like rat osteogenic sarcoma cells. FEBS Lett (1980) 1.08
Studies on calciferol metabolism. 8. Evidence for a cytoplasmic receptor for 1,25-dihydroxy-vitamin D3 in the intestinal mucosa. J Biol Chem (1973) 1.05
Intestinal cytosol binders of 1,25-dihydroxyvitamin D and 25-hydroxyvitamin D. Arch Biochem Biophys (1976) 1.05
Studies on the mode of action of calciferol. XVIII. Evidence for a specific high affinity binding protein for 1,25 dihydroxyvitamin D3 in chick kidney and pancreas. Biochem Biophys Res Commun (1979) 1.01
Unoccupied 1,25-dihydroxyvitamin D3 receptors. Nuclear/cytosol ratio depends on ionic strength. J Biol Chem (1980) 1.01
1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells). Biochem Biophys Res Commun (1980) 0.92
Calcitonin receptors in a cloned human breast cancer cell line (MCF 7). Biochem Biophys Res Commun (1980) 0.90
Normal and malignant breast tissue is a target organ for 1,25-(0H)2 vitamin D3. Clin Endocrinol (Oxf) (1980) 0.89
Highly specific binding of 1,25-dihydroxycholecalciferol in bone cytosol. J Endocrinol (1979) 0.89
Cellular and subcellular localization of 1,25-(OH)2-vitamin D3 in rat kidney: comparison with localization of parathyroid hormone and estradiol. Proc Natl Acad Sci U S A (1980) 0.87
A specific binding protein for 1,25-dihydroxyvitamin D3 in rat intestinal cytosol. Biochem Biophys Res Commun (1977) 0.85
Demonstration of a 1,25-dihydroxycholecalciferol cytoplasmic receptor-like binder in mouse kidney. J Clin Endocrinol Metab (1979) 0.85
A specific 1,25-dihydroxyvitamin D3 binding macromolecule in chicken bone. J Biol Chem (1980) 0.81
Studies on the mechanism of estradiol uptake by rat uterine cells and on estradiol binding to uterine plasma membranes. Adv Exp Med Biol (1979) 0.80
Presence of 1,25-dihydroxy vitamin D receptor in normal and abnormal breast tissue. Prog Biochem Pharmacol (1980) 0.79
Nuclear translocation of the 1,25-dihydroxycholecalciferol receptor in mouse kidney. J Biol Chem (1980) 0.79
A specific, high affinity binding protein for 1 alpha,25-dihydroxy vitamin D in the chick oviduct shell gland. Biochem Biophys Res Commun (1980) 0.79
A technique for differential extraction of nuclear receptors. Methods Enzymol (1975) 0.77
Vitamin D in lactation. I. The localization, specific binding and biological effect of 1,25-dihydroxyvitamin D3 in mammary tissue of lactating rats. Life Sci (1980) 0.77
Recent advances in our understanding of the vitamin D endocrine system. J Steroid Biochem (1979) 0.77
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev (1999) 7.69
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet (1999) 7.14
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Therapeutic approaches to bone diseases. Science (2000) 5.60
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
Osteoblastic cells are involved in osteoclast formation. Endocrinology (1988) 4.37
Modulation of osteoclast differentiation. Endocr Rev (1992) 4.27
A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science (1987) 4.09
Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet (1995) 3.82
Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int (1981) 3.77
Genetic determinants of bone mass in adults. A twin study. J Clin Invest (1987) 3.23
Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy. J Lab Clin Med (1998) 3.18
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci U S A (1987) 3.06
A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis (1999) 2.93
The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology (1989) 2.83
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int (2009) 2.63
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone (2002) 2.40
The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med (1984) 2.33
Malignant glaucoma after laser iridotomy. Ophthalmology (1992) 2.28
Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun (1999) 2.28
Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res (1991) 2.26
A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. Arch Biochem Biophys (1976) 2.23
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A (1992) 2.20
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS (2001) 2.17
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13
A family history of fracture and fracture risk: a meta-analysis. Bone (2004) 2.13
Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology (1999) 2.11
Two-tiered regulation of spatially patterned engrailed gene expression during Drosophila embryogenesis. Nature (1988) 2.08
Screening for osteoporosis: what is the role of heel ultrasound? Med J Aust (1996) 2.01
The hypercalcemia of malignancy: pathogenesis and management. Metabolism (1982) 2.01
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology (2001) 1.98
Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int (1994) 1.95
1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science (1989) 1.88
Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis. Osteoporos Int (2012) 1.80
Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol (1996) 1.79
Risk factors for proximal humerus, forearm, and wrist fractures in elderly men and women: the Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol (2001) 1.78
Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int (2000) 1.77
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology (1998) 1.75
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology (1998) 1.75
Bone mass, lean mass, and fat mass: same genes or same environments? Am J Epidemiol (1998) 1.74
Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum (1987) 1.73
Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci (2001) 1.73
Osteoporosis in elderly men and women: effects of dietary calcium, physical activity, and body mass index. J Bone Miner Res (2000) 1.73
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest (1986) 1.73
Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem (2005) 1.71
Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol (1996) 1.70
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis. Osteoporos Int (2010) 1.69
Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos Int (1999) 1.69
Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int (2008) 1.68
Insulin receptor expression in primary and cultured osteoclast-like cells. Bone (1998) 1.68
Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res (1996) 1.67
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone (1999) 1.66
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology (2001) 1.66
The exclusion of high trauma fractures may underestimate the prevalence of bone fragility fractures in the community: the Geelong Osteoporosis Study. J Bone Miner Res (1998) 1.65
Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res (1987) 1.64
Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density. J Clin Invest (1986) 1.63
Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis (1986) 1.62
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology (2000) 1.61
Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res (1990) 1.61
Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med (1995) 1.60
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest (1993) 1.58
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res (1990) 1.54
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Science (1983) 1.52
Bone density of élite female athletes with stress fractures. Med J Aust (1990) 1.52
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol (2001) 1.52
Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. BMJ (1994) 1.51
Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science (1987) 1.48
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res (2001) 1.47
Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis? J Bone Joint Surg Br (1981) 1.46
A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc (1989) 1.46
Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol (2001) 1.46
Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia. Lancet (1993) 1.45
Osteoporosis prevention and treatment. Med J Aust (2000) 1.41
OsteoPPPorosis--prevention, prevention and prevention. Aust N Z J Med (1991) 1.39
Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res (1983) 1.38
Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun (1985) 1.38
Bone loss, physical activity, and weight change in elderly women: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res (1998) 1.37
Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum (2000) 1.37
Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci U S A (1998) 1.33
Dietary intake and bone mineral density. Bone Miner (1988) 1.31
Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res (1983) 1.31
Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum (1988) 1.31
The use of multiple sites for the diagnosis of osteoporosis. Osteoporos Int (2006) 1.31
Structure of the 5' flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP). Gene (1989) 1.31
Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology (1981) 1.29